Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global JE (Japanese Encephalitis) Vaccine Market: By Type: Inactivated vaccines, Recombinant vaccines, Live attenuated vaccines; By Distribution Channels: Hospital Pharmacies, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global JE (Japanese Encephalitis) Vaccine Market Outlook
The global JE (Japanese encephalitis) vaccine market is expected to grow at a CAGR of 5.9% during the forecast period of 2021-2026.
The increasing mosquito nuisance, rising awareness, and the growing investment in the healthcare sector by the governments across the nations are some of the significant factors contributing to the growth of the global JE (Japanese encephalitis) vaccine market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Properties and Applications
Japanese encephalitis (JE) vaccine is an inactivated vaccine that provides protection against Japanese encephalitis, an infection of the brain caused by the Japanese encephalitis virus (JEV), generally spread by mosquitoes.
The global JE (Japanese encephalitis) vaccine industry can be broadly categorised based on segments like types, distribution channels, and regions.
- Type:
- Inactivated Vaccines
- Recombinant Vaccines
- Live attenuated Vaccines
- Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
The EMR report looks into the regional markets of global JE (Japanese encephalitis) vaccine market like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Market Analysis
The increase in the prevalence and incidence of Japanese encephalitis disease is driving the demand for global JE (Japanese encephalitis) vaccines globally. With the growing trend of routine immunisation or vaccination, the industry is witnessing a strong demand for global JE (Japanese encephalitis) vaccines. Further, the inclusion of Japanese encephalitis vaccination in national immunisation programmes by the governments across the nation is expected to be one of the significant growth drivers for the industry over the forecast period. The growing investment in R&D of these vaccines is aiding the industry growth. Within the Asia Pacific, China and India are at high risk of Japanese encephalitis. Thus, the governments of these countries are carrying out mass vaccinations, providing a further impetus to the industry. However, the lack of awareness may hamper the industry growth over the forecast period.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global JE (Japanese encephalitis) vaccine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Valneva SE (EPA: VLA)
- Bharat Biotech,
- Sanofi SA
- Chengdu Institute of Biological Products
- Others
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Distribution Channel, Region |
| Breakup by Type | Inactivated Vaccine, Recombinant Vaccine, Live attenuated vaccines |
| Breakup by Distribution Channel | Hospital Pharmacies, Retail Pharmacies, E-Commerce |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Valneva SE, Sanofi SA, Bharat Biotech Ltd., Chengdu Institute of Biological Products Co. Ltd., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global JE (Japanese Encephalitis) Vaccine Market Analysis
8.1 Key Industry Highlights
8.2 Global JE (Japanese Encephalitis) Vaccine Historical Market (2016-2020)
8.3 Global JE (Japanese Encephalitis) Vaccine Market Forecast (2021-2026)
8.4 Global JE (Japanese Encephalitis) Vaccine Market by Type
8.4.1 Inactivated Vaccine
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Recombinant Vaccine
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Live attenuated vaccines
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.5 Global JE (Japanese Encephalitis) Vaccine Market by Distribution Channel
8.5.1 Hospital Pharmacies
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Retail Pharmacies
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.3 E-Commerce
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2016-2020)
8.5.3.3 Forecast Trend (2021-2026)
8.6 Global JE (Japanese Encephalitis) Vaccine Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Valneva SE
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Sanofi SA
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Bharat Biotech Ltd.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Chengdu Institute of Biological Products Co. Ltd.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global JE (Japanese Encephalitis) Vaccine Market: Key Industry Highlights, 2016 and 2026
2. Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Type (USD Million), 2016-2020
3. Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Type (USD Million), 2021-2026
4. Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Distribution Channel (USD Million), 2016-2020
5. Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Distribution Channel (USD Million), 2021-2026
6. Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Region (USD Million), 2016-2020
7. Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Region (USD Million), 2021-2026
8. North America JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2016-2020
9. North America JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2021-2026
10. Europe JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2016-2020
11. Europe JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2021-2026
12. Asia Pacific JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2016-2020
13. Asia Pacific JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2021-2026
14. Latin America JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2016-2020
15. Latin America JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2021-2026
16. Middle East and Africa JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2016-2020
17. Middle East and Africa JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2021-2026
18. Global JE (Japanese Encephalitis) Vaccine Market Structure
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 5.9% between 2021 and 2026.
The major drivers of the industry, such as a rise in incidences of Japanese encephalitis disease, increasing health awareness, rising demand from the developing regions, increased government investments in the medical sector, and the growing technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the market include the growing R&D activities, growing demand for routine immunisation, and initiation of national immunisation programmes by the governments across several nations.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Inactivated, recombinant, and live attenuated vaccines are the major types of the product in the industry.
The leading distribution channels in the industry include hospital pharmacies, retail pharmacies, and e-commerce.
The major players in the industry are Valneva SE, Bharat Biotech, Sanofi SA, and Chengdu Institute of Biological Products, among others.
Analyst Review
The Global JE (Japanese encephalitis) vaccine market is being driven by the rising prevalence of Japanese encephalitis due to increasing mosquito nuisance. Aided by the growing knowledge of routine immunisation and favourable government initiatives, the market is expected to witness a robust growth in the forecast period of 2021-2026, growing at a CAGR of 5.9%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the industry can be segmented into inactivated, recombinant, and live attenuated vaccines. On the basis of distribution channels, the industry is divided into hospital pharmacies, retail pharmacies, and e-commerce. The major regional markets for global JE (Japanese encephalitis) vaccine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Valneva SE, Bharat Biotech, Sanofi SA, and Chengdu Institute of Biological Products, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global neutropenia treatment market attained a value of about USD 13.4 billion in 2020, driven by the rise in cancer cases leading to development of novel therapies. Aided by the rising awareness ...
The United States vaccine market attained a value of nearly USD 11.2 billion in 2020, driven by the rising use of mRNA technology in vaccine development. Aided by advancements in biotechnology and gen...
The global immunomodulators market attained an approximate value of USD 175 billion in 2020, driven by the rising prevalence of awareness among the masses regarding immunomodulators. Aided by the risi...
The global telmisartan market attained a value of about USD 3,574 million in 2020, driven by the rising cases of hypertension and cardiovascular diseases. Aided by the robustly growing pharmaceutical ...
The global doxorubicin market attained a value of about USD 1,075.90 million in 2020, driven by the rising cases of cancer worldwide. Aided by government investments in the pharmaceutical sector, the ...
NEWSLETTER